Team Fin­land Health Vis­it to New York and Boston

The Team Fin­land Net­work warm­ly invites Finnish health and life sci­ence com­pa­nies to join a del­e­ga­tion to Boston and New York, two influ­en­tial U.S. hubs for biotech, dig­i­tal health, hos­pi­tal inno­va­tion, and invest­ment. The goal is to show­case Fin­land’s unique inno­va­tion ecosys­tem, cut­ting-edge research, and lead­ing com­pa­nies in the indus­try. The vis­it will be led by a high-lev­el Finnish gov­ern­ment offi­cial.

The vis­it will pro­vide unique access to research insti­tu­tions, hos­pi­tals, inno­va­tion ecosys­tems, and investors, enabling Finnish com­pa­nies to build high-lev­el con­nec­tions, explore col­lab­o­ra­tion oppor­tu­ni­ties, and strength­en Finland’s vis­i­bil­i­ty as a world-class health inno­va­tion part­ner. 

Time: 23 — 26 March 2026

Place: New York and Boston

Reg­is­tra­tions by 21 Feb­ru­ary 2026. Con­tact Tit­ta Houni, titta.houni@businessfinland.fi (@gov.fi 1 Jan 2026 onwards)

Why the U.S. East Coast?

The U.S. East Coast is home to the world’s most con­cen­trat­ed and influ­en­tial health inno­va­tion ecosys­tems, com­bin­ing world-class aca­d­e­m­ic research, top-tier hos­pi­tals, glob­al phar­ma and biotech com­pa­nies, and a pow­er­ful investor net­work. 

READ MORE

Pre­lim­i­nary pro­gram high­lights

The final itin­er­ary is sub­ject to change based on com­pa­ny par­tic­i­pa­tion and the avail­abil­i­ty of meet­ing hosts.

New York, March 23

  • Deer­field Man­age­ment – a lead­ing health­care invest­ment firm and trans­la­tion­al research part­ner.
  • Cure Inno­va­tion Hub – an ecosys­tem con­nect­ing inno­va­tors from con­cept to com­mer­cial­iza­tion.
  • Pfiz­er vis­it
  • Ori­on vis­it
  • Memo­r­i­al Sloan Ket­ter­ing – a glob­al leader in can­cer research and treat­ment.
  • NYC EDC

Boston, March 24–25 (pos­si­bil­i­ty to attend the con­fer­ence on the 26th)

  • Broad Insti­tute – world-lead­ing research in genomics and dis­ease biol­o­gy.
  • MIT Indus­tri­al Liai­son Pro­gram – con­nect­ing indus­try with cut­ting-edge MIT research and inno­va­tion.
  • Lab­Cen­tral – a pre­mier incu­ba­tor sup­port­ing ear­ly-stage biotech star­tups.
  • Mass­BIO & MassMEDIC – indus­try orga­ni­za­tions dri­ving growth across the life sci­ence and medtech sec­tors.
  • Cam­bridge Inno­va­tion Cen­ter (CIC) – a hub for glob­al col­lab­o­ra­tion and start­up activ­i­ty in Kendall Square.
  • Brigham and Women’s Hos­pi­tal and Boston Children’s Hos­pi­tal – lead­ing aca­d­e­m­ic med­ical cen­ters and teach­ing hos­pi­tals of Har­vard Med­ical School, locat­ed in the
  • Long­wood Med­ical Area, which hosts numer­ous world-lead­ing hos­pi­tals, health schools, and research insti­tutes. There is a pos­si­bil­i­ty to meet with inno­va­tion and research teams fos­ter­ing start­up and inno­va­tion pro­grams across the hos­pi­tal sys­tem.
  • MassBio’s 2026 State of Pos­si­ble Con­fer­ence, March 26

Who should attend? 

This del­e­ga­tion is open to Finnish com­pa­nies and orga­ni­za­tions in the health and life sci­ences sec­tors that are already active in the U.S. mar­ket and seek­ing growth, part­ner­ships, and vis­i­bil­i­ty, includ­ing: 

  • Oncol­o­gy and immunol­o­gy
  • Imag­ing
  • Health data and AI
  • Phar­ma

Par­tic­i­pants will gain

  • First-hand insights into U.S. hos­pi­tal inno­va­tion and invest­ment mod­els
  • Access to deci­sion-mak­ers at lead­ing U.S. hos­pi­tals, research insti­tu­tions
  • Net­work­ing oppor­tu­ni­ties with East Coast health­care lead­ers
  • Access, vis­i­bil­i­ty, and cred­i­bil­i­ty through the Team Fin­land del­e­ga­tion

Par­tic­i­pa­tion fee

To cov­er the expens­es relat­ed to arrang­ing the vis­it, a max­i­mum par­tic­i­pa­tion fee will be invoiced as fol­lows:

  • Micro busi­ness­es and SMEs: EUR 1190 + 25,5% VAT per per­son
  • Major com­pa­nies: EUR 1400 + 25,5% VAT per per­son

A 25% dis­count on the par­tic­i­pa­tion fee will be grant­ed for each addi­tion­al rep­re­sen­ta­tive from the par­tic­i­pat­ing com­pa­ny. The par­tic­i­pa­tion fee will be invoiced after the vis­it, based on the actu­al costs. The invoiced fee will not exceed the amounts men­tioned above. The par­tic­i­pa­tion fee does not include flights or accom­mo­da­tion for the del­e­gate, nor meals out­side the vis­it pro­gram.

READ MORE

Con­tact per­sons

Pro­gram:
Tit­ta Houni, Senior Advi­sor, USA
titta.houni@businessfinland.fi (@gov.fi 1 Jan 2026 onwards)

Tar­ja Enala, Head of Pro­gram, Health 360
tarja.enala@businessfinland.fi

Prac­ti­cal­i­ties:
Anni­ka Lip­sa­nen-Brito, Man­ag­er, Del­e­ga­tions
annika.lipsanen-brito@businessfinland.fi (@gov.fi 1 Jan 2026 onwards)

Source: Busi­ness Fin­land